{"id":"https://openalex.org/W1997479221","doi":"https://doi.org/10.1021/jm00161a028","title":"Azasteroids: structure-activity relationships for inhibition of 5.alpha.-reductase and of androgen receptor binding","display_name":"Azasteroids: structure-activity relationships for inhibition of 5.alpha.-reductase and of androgen receptor binding","publication_year":1986,"publication_date":"1986-11-01","ids":{"openalex":"https://openalex.org/W1997479221","doi":"https://doi.org/10.1021/jm00161a028","mag":"1997479221","pmid":"https://pubmed.ncbi.nlm.nih.gov/3783591"},"language":"en","primary_location":{"id":"doi:10.1021/jm00161a028","doi":"https://doi.org/10.1021/jm00161a028","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00161a028","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030825466","display_name":"Gary H. Rasmusson","orcid":"https://orcid.org/0000-0002-8612-1369","observed_orcids":["https://orcid.org/0000-0002-8612-1369"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary H. Rasmusson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Glenn F. Reynolds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Glenn F. Reynolds","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036620197","display_name":"Nathan G. Steinberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan G. Steinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001094934","display_name":"Edward Walton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Walton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004704325","display_name":"Gool F. Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gool F. Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103437108","display_name":"Tehming Liang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tehming Liang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108215906","display_name":"Margaret A. Cascieri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret A. Cascieri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103679394","display_name":"Anne H. Cheung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne H. Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113792000","display_name":"Jerry R. Brooks","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerry R. Brooks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Charles Berman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Berman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.7813,"has_fulltext":false,"cited_by_count":256,"citation_normalized_percentile":{"value":0.88092603,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"29","issue":"11","first_page":"2298","last_page":"2315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2930000126361847,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2930000126361847,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.2865999937057495,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13736","display_name":"Steroid Chemistry and Biochemistry","score":0.08699999749660492,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5alpha-reductase-inhibition","display_name":"5\u03b1-reductase inhibition","score":0.8199999928474426},{"id":"https://openalex.org/keywords/androgen-receptor-binding","display_name":"androgen receptor binding","score":0.9070000052452087},{"id":"https://openalex.org/keywords/dihydrotestosterone","display_name":"dihydrotestosterone","score":0.8560000061988831},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9520000219345093},{"id":"https://openalex.org/keywords/17beta-hydroxy-steroids","display_name":"17\u03b2-hydroxy steroids","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9127963781356812},{"id":"https://openalex.org/C2910366748","wikidata":"https://www.wikidata.org/wiki/Q4639645","display_name":"5 Alpha-Reductase Inhibitor","level":5,"score":0.7454591989517212},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.7220807075500488},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.6361079216003418},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.46215492486953735},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.442035436630249},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.43328186869621277},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.42869114875793457},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.40147078037261963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2746615409851074},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15163883566856384},{"id":"https://openalex.org/C2775874879","wikidata":"https://www.wikidata.org/wiki/Q424167","display_name":"Finasteride","level":4,"score":0.12838515639305115},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.0657360851764679},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.05991515517234802},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013260","descriptor_name":"Steroids, Heterocyclic","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00161a028","doi":"https://doi.org/10.1021/jm00161a028","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00161a028","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:3783591","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3783591","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2031647291","https://openalex.org/W1893052060","https://openalex.org/W2019075007","https://openalex.org/W2953238281","https://openalex.org/W2029706340","https://openalex.org/W2038726239","https://openalex.org/W2089393196","https://openalex.org/W2041893439","https://openalex.org/W2086537771","https://openalex.org/W2002036322"],"abstract_inverted_index":{"A":[0,39],"series":[1,64],"of":[2,14,22,24,37,42,49,108,180,192,208],"steroids,":[3],"primarily":[4],"4-azasteroids,":[5],"were":[6,35,104,112,164],"prepared":[7,113],"and":[8,16,21,41,65,77,97,102,130,143],"tested":[9],"in":[10,61,80,126,166,172,215],"vitro":[11],"as":[12],"inhibitors":[13],"human":[15,129,168],"rat":[17,28,131,174,182],"prostatic":[18],"5":[19,123],"alpha-reductase":[20,124],"binding":[23],"dihydrotestosterone":[25],"to":[26],"the":[27,38,46,50,57,62,81,109,119,128,156,167,173,181,193,216,225],"androgen":[29,183],"receptor.":[30],"The":[31,106,195],"primary":[32],"structural":[33],"modifications":[34,55],"changes":[36,79],"ring":[40,90],"moieties":[43],"attached":[44],"at":[45,94,211,224],"C-17":[47,110,146],"position":[48],"steroid":[51],"nucleus.":[52,159],"New":[53],"A-ring":[54],"included":[56],"4-cyano-3-oxo-delta":[58],"4":[59,141],"system":[60],"carbocyclic":[63],"1":[66,68,70],"alpha-CN,":[67],"alpha-CH3,":[69],"alpha,2":[71],"alpha-CH2,":[72],"2":[73],"beta-F,":[74],"2-aza,":[75],"2-oxa,":[76],"A-homo":[78],"3-oxo-4-aza":[82],"series.":[83],"In":[84],"addition,":[85],"4-azasteroids":[86],"with":[87,136,144],"a":[88,145,150,219],"D-homo":[89],"or":[91,99,213],"methyl":[92],"substitution":[93,138],"C-7":[95],"(alpha":[96,101],"beta)":[98,103],"C-16":[100],"prepared.":[105],"majority":[107],"substituents":[111],"from":[114,118,188],"reactive":[115],"intermediates":[116],"derived":[117],"17":[120,196],"beta-COOH.":[121],"Enhanced":[122],"inhibition":[125,179,191],"both":[127],"enzyme":[132,169],"assays":[133],"is":[134],"seen":[135],"4-CN":[137],"on":[139,155],"3-oxo-delta":[140],"steroids":[142],"side":[147],"chain":[148],"incorporating":[149],"lipophilically":[151],"substituted":[152],"semipolar":[153],"group":[154],"4-aza-3-oxo-5":[157],"alpha-androstane":[158],"Fewer":[160],"highly":[161],"active":[162],"compounds":[163],"found":[165],"assay":[170],"than":[171,202],"assay.":[175],"Structural":[176],"requirements":[177],"for":[178,190],"receptor":[184,230],"are":[185],"much":[186],"different":[187],"those":[189],"enzyme.":[194],"beta-OH":[197],"moiety":[198],"enhances":[199],"potency":[200],"more":[201],"any":[203],"other":[204],"feature":[205],"while":[206],"introduction":[207],"double":[209],"bonds":[210],"C-1":[212],"C-5":[214],"azasteroid":[217],"gives":[218],"small":[220],"improvement.":[221],"Azasteroids":[222],"unsubstituted":[223],"4-position":[226],"show":[227],"greatly":[228],"diminished":[229],"activity.":[231]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}